1-3 of 3
Kelly L. Davison
Close
Sort by
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023
Journal Articles

Improving End of Life Care for Hematology-Oncology Patients within the Rossy Cancer Network

Victoria Korsos, BSc, Allaa Ali, MPH, Doneal Thomas, M.Phil, M.Sc, Kelly L. Davison, MD PhD, Sarit Assouline, MD, Luca Petruccelli, Chantal Cassis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4775.
https://doi.org/10.1182/blood-2019-129428
Published: 2019
Journal Articles

Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network

Shen Li, MD, Allaa Ali, MPH, Alexander Lawandi, MD BS, BA, MSc, Myriam Fernandez, RN, Caroline Rousseau, PhD, Doneal Thomas, M.Phil, M.Sc, Sarit Assouline, Chantal Cassis, MD, Todd Campbell Lee, MD MPH, Kelly L. Davison, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2256.
https://doi.org/10.1182/blood-2018-99-119079
Published: 2018